Struma ovarii screening: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*There is insufficient evidence to recommend routine screening for Struma ovarii. | *There is insufficient evidence to recommend routine screening for Struma ovarii. | ||
*However, in cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. <ref name="pmid19289330">{{cite journal| author=McGill JF, Sturgeon C, Angelos P| title=Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. | journal=Endocr Pract | year= 2009 | volume= 15 | issue= 2 | pages= 167-73 | pmid=19289330 | doi=10.4158/EP.15.2.167 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19289330 | *However, in cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. <ref name="pmid19289330">{{cite journal| author=McGill JF, Sturgeon C, Angelos P| title=Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. | journal=Endocr Pract | year= 2009 | volume= 15 | issue= 2 | pages= 167-73 | pmid=19289330 | doi=10.4158/EP.15.2.167 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19289330 }} </ref> | ||
==References== | ==References== | ||
Revision as of 21:35, 19 August 2017
|
Struma ovarii Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Struma ovarii screening On the Web |
|
American Roentgen Ray Society Images of Struma ovarii screening |
|
Risk calculators and risk factors for Struma ovarii screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for Struma ovarii.
Screening
- There is insufficient evidence to recommend routine screening for Struma ovarii.
- However, in cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. [1]
References
- ↑ McGill JF, Sturgeon C, Angelos P (2009). "Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation". Endocr Pract. 15 (2): 167–73. doi:10.4158/EP.15.2.167. PMID 19289330.